Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Astellas Pharma Inc (ALPMY)
Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 21,639,950
  • Shares Outstanding, K 1,809,663
  • Annual Sales, $ 11,418 M
  • Annual Income, $ 742,000 K
  • 60-Month Beta 0.49
  • Price/Sales 1.97
  • Price/Cash Flow 9.03
  • Price/Book 1.96
Trade ALPMY with:
  • Price/Earnings ttm 22.70
  • Earnings Per Share ttm 0.54
  • Most Recent Earnings -0.01 on 11/01/23
  • Next Earnings Date 10/30/23
  • Annual Dividend & Yield 0.32 (2.68%)
  • Most Recent Dividend 0.168 on 09/27/23
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.27
  • Growth Rate Est. (year over year) +369,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.2500 +5.16%
on 11/13/23
12.5499 -5.74%
on 12/07/23
+0.0500 (+0.42%)
since 11/10/23
3-Month
11.2500 +5.16%
on 11/13/23
15.4400 -23.38%
on 09/15/23
-3.0700 (-20.60%)
since 09/11/23
52-Week
11.2500 +5.16%
on 11/13/23
16.9100 -30.04%
on 05/22/23
-3.7800 (-24.22%)
since 12/09/22

Most Recent Stories

More News
3 Rising Pharma Stocks to Consider Buying Now

The pharmaceutical sector is transforming due to the swift uptake of digital solutions and worldwide spending growth. Hence, fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Astellas...

ALPMY : 11.8300 (-1.07%)
LLY : 574.67 (-3.91%)
SUPN : 26.26 (-2.42%)
Merck & Co. (MRK) Q3 Earnings Assessment: Is the Pharma Stock a Buy or Sell?

In the wake of Merck & Co.'s (MRK) better-than-expected fiscal third-quarter showing and the enigmatic potential hinted at by its clinical successes, is this pharmaceutical powerhouse a hidden gem for...

ABBV : 150.75 (+0.98%)
ALPMY : 11.8300 (-1.07%)
AZN : 63.39 (+0.22%)
DSNKY : 28.3300 (+2.76%)
MRK : 104.08 (+0.32%)
NVS : 96.92 (+0.64%)
3 Promising Pharma Stocks to Keep on Your Radar

The pharma industry’s prospects look bright, thanks to rising demand for generic and innovative drugs and technological advancements. Hence, adding fundamentally strong pharma stocks Astellas Pharma...

ALPMY : 11.8300 (-1.07%)
GSK : 36.26 (+0.89%)
SNY : 47.06 (+1.60%)
TEVA : 9.37 (-4.58%)
Here Are the 3 George Soros Stocks Most Likely to Turn $200,000 Into $1 Million Over the Next 20 Years

The multibillionaire's portfolio features some moneymaking ideas.

ALPMY : 11.8300 (-1.07%)
GOOG : 134.29 (-1.72%)
GOOGL : 132.81 (-1.61%)
AMZN : 146.05 (-0.93%)
MSFT : 369.92 (-1.15%)
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?

Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.

AMGN : 271.45 (+0.87%)
BMY : 50.69 (+0.76%)
LLY : 574.67 (-3.91%)
XLV : 132.52 (+0.34%)
HZNP : 116.30 (+0.04%)
JNJ : 154.42 (unch)
MRK : 104.08 (+0.32%)
NVS : 96.92 (+0.64%)
NVO : 96.02 (-0.64%)
XPH : 38.34 (+0.29%)
ALPMY : 11.8300 (-1.07%)
3 Pharma Stocks to Buy for Value Investors

The pharma industry is well-positioned to witness significant growth due to the continuous advancements in artificial intelligence and increasing demand for innovative drugs. Therefore, fundamentally strong...

ALPMY : 11.8300 (-1.07%)
ISEE : 39.95 (+0.38%)
MRK : 104.08 (+0.32%)
TARO : 37.90 (+0.03%)
3 Stocks With MAJOR Growth Potential

Considering the recent robust economic indicators and growing optimism, I think fundamentally strong growth stocks América Móvil (AMX), Astellas Pharma (ALPMY), and Bruker (BRKR) could be ideal investments....

ALPMY : 11.8300 (-1.07%)
AMX : 18.36 (+0.22%)
BRKR : 69.44 (+2.16%)
ISEE : 39.95 (+0.38%)
Secure Your Portfolio With These 3 Pharma Stocks

With rising global healthcare needs, investing in fundamentally sound pharma stocks AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and Astellas Pharma (ALPMY) could help secure your portfolio by offering...

ALPMY : 11.8300 (-1.07%)
AZN : 63.39 (+0.22%)
BMY : 50.69 (+0.76%)
Is Catalyst Pharmaceuticals (CPRX) a Quality Investment?

Biopharmaceutical company Catalyst Pharmaceuticals (CPRX) delivered a robust performance in the first quarter of 2023. However, it fell short of analysts’ estimates. Let’s dig into some of its financial...

ABBV : 150.75 (+0.98%)
ALPMY : 11.8300 (-1.07%)
CPRX : 13.74 (-2.90%)
NVO : 96.02 (-0.64%)
Should You Buy Into Pfizer (PFE) Today?

Despite a slowdown of Covid-19 vaccine sales in the last reported quarter, biopharmaceutical giant Pfizer (PFE) is positioned to deliver robust growth this year and beyond, thanks to the strength of its...

ALPMY : 11.8300 (-1.07%)
JNJ : 154.42 (unch)
MRK : 104.08 (+0.32%)
PFE : 28.51 (-0.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 12.0620
2nd Resistance Point 12.0260
1st Resistance Point 11.9920
Last Price 11.8300
1st Support Level 11.9220
2nd Support Level 11.8860
3rd Support Level 11.8520

See More

52-Week High 16.9100
Fibonacci 61.8% 14.7479
Fibonacci 50% 14.0800
Fibonacci 38.2% 13.4121
Last Price 11.8300
52-Week Low 11.2500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar